Expanded programme on immunization. Global Advisory Group--Part II.
D003362:Cost-Benefit Analysis; D014943:Global Health; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008458:Measles Vaccine / Q000008:administration & dosage; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D011314:Preventive Health Services / Q000458:organization & administration*; D013745:Tetanus Toxoid / Q000008:administration & dosage; D014611:Vaccination
D008458:Measles Vaccine; D011054:Poliovirus Vaccine, Inactivated; D013745:Tetanus Toxoid